Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Corrigendum] Novel polygodial analogs P3 and P27: Efficacious therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma.
De La Chapa J, Singha PK, Sallaway M, Self K, Nasreldin R, Dasari R, Hart M, Kornienko A, Just J, Smith JA, Bissember AC, Gonzales CB. De La Chapa J, et al. Among authors: hart m. Int J Oncol. 2020 Apr;56(4):1045. doi: 10.3892/ijo.2020.4978. Epub 2020 Feb 7. Int J Oncol. 2020. PMID: 32319547 Free PMC article.
The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis.
De La Chapa JJ, Singha PK, Self KK, Sallaway ML, McHardy SF, Hart MJ, McGuff HS, Valdez MC, Ruiz F 2nd, Polusani SR, Gonzales CB. De La Chapa JJ, et al. J Oral Pathol Med. 2019 May;48(5):389-399. doi: 10.1111/jop.12843. Epub 2019 Apr 4. J Oral Pathol Med. 2019. PMID: 30825343 Free PMC article.
Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215].
De La Chapa J, Valdez M, Ruiz F 2nd, Gonzales K, Mitchell W, McHardy SF, Hart MJ, Polusani SR, Gonzales CB. De La Chapa J, et al. Among authors: hart mj. Bioorg Med Chem. 2019 Jun 1;27(11):2280. doi: 10.1016/j.bmc.2019.04.007. Epub 2019 Apr 20. Bioorg Med Chem. 2019. PMID: 31014563 No abstract available.
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.
Lin AL, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih YY, Muir E, Solano Fonseca R, Strong R, Richardson AG, Lechleiter JD, Fox PT, Galvan V. Lin AL, et al. Among authors: hart mj. J Cereb Blood Flow Metab. 2013 Sep;33(9):1412-21. doi: 10.1038/jcbfm.2013.82. Epub 2013 Jun 26. J Cereb Blood Flow Metab. 2013. PMID: 23801246 Free PMC article.
mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging.
Van Skike CE, Lin AL, Roberts Burbank R, Halloran JJ, Hernandez SF, Cuvillier J, Soto VY, Hussong SA, Jahrling JB, Javors MA, Hart MJ, Fischer KE, Austad SN, Galvan V. Van Skike CE, et al. Aging Cell. 2020 Jan;19(1):e13057. doi: 10.1111/acel.13057. Epub 2019 Nov 6. Aging Cell. 2020. PMID: 31693798 Free PMC article.
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.
Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V. Halloran J, et al. Among authors: hart mj. Neuroscience. 2012 Oct 25;223:102-13. doi: 10.1016/j.neuroscience.2012.06.054. Epub 2012 Jun 28. Neuroscience. 2012. PMID: 22750207 Free PMC article.
1,453 results